Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Independent Validation of Candidate Breast Cancer Serum Biomarkers Identified by Mass Spectrometry

14 Oct 2005

Abstract excerpt

BACKGROUND: We previously selected a panel of 3 breast cancer biomarkers (BC1, BC2, and BC3) from serum samples collected at a single hospital based on their collective contribution to the optimal separation of breast cancer patients and noncancer controls by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). The identities and general applicability of these markers,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Advanced Proteomics Techniques and Applications
Share to Clusterin in disease pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16223889
DOI: 10.1373/clinchem.2005.052878

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Independent Validation of Candidate Breast Cancer Serum Biomarkers Identified by Mass SpectrometryPMID 16223889Read ↗

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.Semantic proximity Read ↗

Extracellular matrix proteins as diagnostic markers of breast carcinomaSemantic proximity Read ↗

Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications.Semantic proximity Read ↗

Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discoverySemantic proximity Read ↗

SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.Semantic proximity Read ↗

Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysisSemantic proximity Read ↗

Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screeningSemantic proximity Read ↗

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.